Additionally, it was demonstrated that brain areas that are affected early in the development of PD have particularly high levels of glial fibrillary acidic protein (GFAP) and that there is an enteric glial reaction that leads to the overexpression of GFAP in PD patients [28,29,30]. The gene discussed is GFAP; the disease is Parkinson disease.